Neuralink has reached a major milestone in its brain-computer interface program, with 21 human participants now using the coin-sized Telepathy implant to control computers, phones, and robotic arms using thought alone. Two years after the first implant, recipients including college student Noland, robotic arm operator Nick, and artist Audrey report significant breakthroughs, with no serious device-related issues and information transfer speeds topping 10 bits per second.

At a January 2026 event, Elon Musk announced Neuralink’s next major initiative: Blindsight, a brain implant designed to restore vision to the blind by directly delivering camera images to the visual cortex. Musk emphasized that the system could enable sight for individuals who have lost their eyes or optic nerves, as well as those blind from birth. Initial trials will provide low-resolution vision, with plans to scale to high-definition and include enhanced capabilities such as infrared and ultraviolet perception, akin to Star Trek’s Geordi La Forge.

The Neuralink device received FDA breakthrough status in 2024 and aims to serve the estimated 36 million blind people worldwide, according to World Health Organization data. Human trials for Blindsight are slated to begin in late 2026, potentially outpacing conventional retinal prosthetics, which only restore partial vision in select cases. Future updates to the Telepathy implant will triple electrode counts and deliver more advanced capabilities by late 2026, further expanding its potential for thought-based control of external devices.

Musk described the initiative as transformative, saying, “Our next product, Blindsight, will enable those who have total loss of vision, including if they’ve never seen, to be able to see again.” The combined progress in telepathy and vision restoration underscores Neuralink’s goal of merging neural interfaces with real-world applications, from communication to sensory enhancement.